Genocea Biosciences, Inc. (GNCA) Social Stream



Genocea Biosciences, Inc. (GNCA): $1.76

0.02 (+1.15%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add GNCA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 500

in industry

Genocea Biosciences Inc (GNCA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering GNCA.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $8 $4.4 $6.1 $1.74 250.57%

The Trend in the Analyst Price Target


GNCA's average price target has moved down $0.38 over the prior 176 days.

GNCA reports an average of 180.64% for its upside potential over the past 18 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-15 4 8 4.4 6.10 1.780 242.7%
2021-09-11 4 8 4.4 6.10 2.020 201.98%
2021-09-04 4 8 4.4 6.10 1.820 235.16%
2021-08-28 4 8 4.4 6.10 1.780 242.7%
2021-08-09 4 8 4.4 6.10 1.930 216.06%
2021-08-07 4 8 4.4 6.10 1.980 208.08%
2021-08-05 4 8 4.4 6.10 2.000 205%
2021-08-01 4 8 4.4 6.10 2.020 201.98%
2021-07-24 5 9 4.4 6.68 2.040 227.45%
2021-07-17 5 9 4.4 6.68 2.115 215.84%
2021-07-10 5 9 4.4 6.68 2.120 215.09%
2021-07-03 5 9 4.4 6.68 2.250 196.89%
2021-06-21 5 9 4.4 6.68 2.200 203.64%
2021-06-13 5 9 4.4 6.68 2.530 164.03%
2021-06-05 5 9 4.4 6.68 2.320 187.93%
2021-05-22 5 9 4.4 6.68 2.320 187.93%
2021-05-15 5 9 4.4 6.68 2.190 205.02%
2021-05-04 5 9 4.4 6.68 2.650 152.08%
2021-04-25 5 9 4.4 6.68 2.820 136.88%
2021-04-17 5 9 4.4 6.68 2.210 202.26%
2021-03-23 5 9 4.4 6.48 2.840 128.17%
2021-03-20 5 9 4.4 6.48 2.980 117.45%
2021-03-13 5 9 4.4 6.48 2.960 118.92%
2021-03-06 5 9 4.4 6.48 2.690 140.89%
2021-02-27 5 9 4.4 6.48 3.040 113.16%
2021-02-01 5 9 4.0 6.60 2.990 120.74%
2021-01-30 5 9 4.0 6.60 2.800 135.71%
2021-01-23 5 9 4.0 6.60 3.030 117.82%
2021-01-16 5 9 4.0 6.60 2.710 143.54%
2021-01-09 5 9 4.0 6.60 2.430 171.6%
2021-01-02 5 9 4.0 6.60 2.420 172.73%
2020-12-26 5 9 4.0 6.60 2.580 155.81%
2020-12-19 5 9 4.0 6.60 2.240 194.64%
2020-11-26 5 9 4.0 6.60 2.010 228.36%
2020-11-09 5 9 4.0 6.60 2.100 214.29%
2020-10-12 5 18 5.0 9.40 NA NA%
2020-07-29 5 18 5.0 9.40 NA NA%
2020-07-23 5 18 5.0 11.40 NA NA%
2020-06-22 5 32 5.0 16.00 NA NA%
2020-04-08 5 32 5.0 16.00 NA NA%

GNCA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.2 3 2 0 0 0 5

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Genocea Biosciences Inc's upside potential (average analyst target price relative to current price) is greater than 92% of all US stocks.
  • GNCA has a higher average analyst price target than 11.12% of all US stocks.
  • Genocea Biosciences Inc's variance in analysts' estimates is lower than 16.85% of stocks in the small market cap category.
  • Genocea Biosciences Inc's number of analysts covering the stock is greater than 34.17% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, SIOX, SQZ and CYCC are the three stocks most similar to Genocea Biosciences Inc regarding the price target and analyst recommendation information presented here.

What is the outlook for GNCA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7744 seconds.